期刊
DIABETES-METABOLISM RESEARCH AND REVIEWS
卷 34, 期 8, 页码 -出版社
WILEY
DOI: 10.1002/dmrr.3056
关键词
diabetic cardiomyopathy; long noncoding RNAs; prevention and treatment strategies
资金
- Zhengzhou University Overseas Virtual Research Institute Special Fund
- Henan Science and Technology Huimin Plan Fund [162207310005]
- Zhengzhou City Science and Technology Innovation Talents Training Program: Leading Talent Fund [10LJRC175]
Diabetic cardiomyopathy (DCM) can cause extensive necrosis of the heart muscle by metabolic disorders and microangiopathy, with subclinical cardiac dysfunction, and eventually progress to heart failure, arrhythmia, and cardiogenic shock; severe patients may even die suddenly. Long noncoding RNAs (lncRNAs) are a class of nonprotein-coding RNAs longer than 200 nucleotides. They have critical roles in various biological processes, including gene expression regulation, genomic imprinting, nuclear-cytoplasmic trafficking, RNA splicing, and translational control. Recent studies indicated that lncRNAs extensively participate in the development of diverse cardiac diseases, such as cardiac ischaemia, hypertrophy, and heart failure. Little is known about lncRNA in DCM. In this review, we summarize the current literature on lncRNAs in DCM studies, aiming to provide new methods for DCM's future prevention and treatment strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据